• MRP2 as a Targetable Oxaliplatin Resistance Factor in Gastrointestinal Cancer

      Biswas, Riya (Auckland University of Technology, 2018)
      Despite the severe adverse effects, toxicity and limited efficacy due to the development of multidrug resistance (MDR), chemotherapy is still the treatment of choice for most of the cancer patients. One of the formidable ...
    • Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer

      Bugde, Piyush (Auckland University of Technology, 2019)
      Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumours. gemcitabine-based regimens have been used as front-line treatments for patients with advanced pancreatic cancer. gemcitabine may initially ...